Infectious Diseases in Critical Care Medicine

38. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for
    management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36(1):296–327.


39. Cunha BA. Sepsis and septic shock: selection of empiric antimicrobial therapy. Crit Care Clin 2008;
    24(2):313–334.


40. Mylonakis E, Calderwood SB. Infective endocarditis in adults. New Engl J Med 2001; 345(18):1318–1330.


41. Akpunonu BE, Bittar S, Phinney RC, et al. Prevention of infective endocarditis: the new AHA
    guideline and the elderly. Geriatrics 2008; 63(8):12–19.


42. Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and
    nondental exposures. Circulation 2000; 102(23):2842–2848.


43. Manoff SB, Vlahov D, Herskowitz A, et al. Human immunodeficiency virus infection and infective
    endocarditis among injecting drug users. Epidemiology 1996; 7(6):566–570.


44. Brown PD, Levine DP. Infective endocarditis in the injection drug user. Infect Dis Clin North Am
    2002; 16(3):645–665.


45. Crawford MH, Durack DT. Clinical presentation of infective endocarditis. Cardiol Clin 2003; 21(2):
    159–166.


46. Barr J, Danielsson D. Septic gonococcal dermatitis. Br Med J 1971; 1(747):482–485.


47. Holmes KK, Counts GW, Beaty HN. Disseminated gonococcal infection. Ann Intern Med 1971; 74(6):
    979–993.


48. Kerle KK, Mascola JR, Miller TA. Disseminated gonococcal infection. Am Fam Physician 1992; 45(1):
    209–214.


49. Handsfield HH. Disseminated gonococcal infection. Clin Obstet Gynecol 1975; 18(1):131–142.


50. Abu-Nassar H, Hill N, Fred HL, et al. Cutaneous manifestations of gonococcemia. A review of
    14 cases. Arch Intern Med 1963; 112:731–737.


51. Krol-van Straaten MJ, Landheer JE, de Maat CE. Capnocytophaga canimorsus (formerly DF-2)
    infections: review of the literature. Neth J Med 1990; 36(5–6):304–309.


52. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in human: review of the
    literature and case report. Eur J Epidemiol 1996; 12(5):521–533.


53. Kullberg BJ, Westendorp RG, van’t Wout JW, et al. Purpura fulminans and symmetrical peripheral
    gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia—a complication of
    dog bite. Medicine 1991; 70(5):287–292.


54. Macrea MM, McNamee M, Martin TJ. Acute onset of fever, chills, and lethargy in a 36 year old
    woman. Chest 2008; 133(6):1505–1507.


55. Centers for Disease Control and Prevention (CDC). Dengue fever fact sheet. 2008. Available at:
    http://www.cdc.gov/ncidod/dvbid/dengue/.


56. Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel.
    Med Clin North Am 2008; 92(6):1377–1390.


57. Guha-Sapir D, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg
    Themes Epidemiol 2005; 2(1):1–10.


58. World Health Organization (WHO). Dengue and dengue haemorrhagic fever. Fact sheet #117, 2008.


59. Calisher CH. Persistent emergence of dengue. Emerg Infect Dis 2005; 11(5):738–739.


60. Pincus LB, Grossman ME, Fox LP. The exanthema of dengue fever: clinical features of two US
    tourists traveling abroad. J Am Acad Dermatol 2008; 58(2):308–316.


61. Shirtcliffe P, Cameron E, Nicholson KG, et al. Don’t forget dengue! Clinical features of dengue fever
    in returning travelers. J R Coll Physicians Lond 1998; 32(3):235–237.


62. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute
    dengue illness. J Infect Dis 1997; 176(2):313–321.


63. Kao CL, King CC, Chao DY, et al. Laboratory diagnosis of dengue virus infection: current and future
    perspectives in clinical diagnosis and public health. J Microbiol Immunol Infect 2005; 38(1):5–16.


64. Walker DH. Tick-transmitted infectious diseases in the United States. Ann Rev Public Health 1998;
    19:237–269.


65. Taege AJ. Tick trouble: overview of tick-borne diseases. Cleve Clin J Med 2000; 67(4):241, 245–249.


66. Lyme disease—United States, 1999. MMWR Morb Mortal Wkly Rep 2001; 50(10):181–185.


67. Gayle A, Ringdahl E. Tick-borne diseases. Am Fam Physician 2001; 64(3):461–466.


68. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004; 113(8):
    1093–1101.


69. Edlow JA. Lyme disease and related tick-borne illnesses. Ann Emerg Med 1999; 33(6):680–693.


70. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331(19):
    1272–1285.


71. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209(2):123–129.


72. Ogundele O, Silverberg MA, Foster J. Erythema Multiforme. Available at: emedicine.medscape.
    com/article/762333-overview, 2009:1–15.

Fever and Rash in Critical Care 43